Amina Carlebach

522 total citations
15 papers, 432 citations indexed

About

Amina Carlebach is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Amina Carlebach has authored 15 papers receiving a total of 432 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 8 papers in Virology and 7 papers in Hepatology. Recurrent topics in Amina Carlebach's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (8 papers) and Hepatitis C virus research (7 papers). Amina Carlebach is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (8 papers) and Hepatitis C virus research (7 papers). Amina Carlebach collaborates with scholars based in Germany, United Kingdom and United States. Amina Carlebach's co-authors include Schlomo Staszewski, Veronica Miller, Caroline Sabin, Annette Haberl, Peter Gute, A.D. Hill, E. B. Helm, Christoph Stephan, Thomas A. Lutz and Markus Bickel and has published in prestigious journals such as The Journal of Infectious Diseases, Journal of Hepatology and AIDS.

In The Last Decade

Amina Carlebach

14 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Amina Carlebach Germany	11	346	255	132	122	66	15	432
E DeJesus United States	14	435 1.3×	257 1.0×	178 1.3×	171 1.4×	148 2.2×	28	568
Erkki Lathouwers United States	12	568 1.6×	410 1.6×	171 1.3×	147 1.2×	133 2.0×	31	650
A Moll Germany	7	359 1.0×	272 1.1×	136 1.0×	87 0.7×	50 0.8×	7	420
Josef Jost Switzerland	9	280 0.8×	140 0.5×	105 0.8×	277 2.3×	44 0.7×	13	473
Greet Beets United States	6	364 1.1×	298 1.2×	123 0.9×	60 0.5×	35 0.5×	8	430
Rodica Van Solingen‐Ristea United States	11	296 0.9×	187 0.7×	119 0.9×	77 0.6×	38 0.6×	31	375
Corinne Rancinan France	8	334 1.0×	248 1.0×	73 0.6×	48 0.4×	152 2.3×	13	424
Stephan Klauke Germany	10	252 0.7×	201 0.8×	75 0.6×	49 0.4×	90 1.4×	24	332
Lucinda R. Gilde United States	3	573 1.7×	513 2.0×	57 0.4×	33 0.3×	78 1.2×	3	627
Teresa García-Benayas Spain	13	395 1.1×	289 1.1×	85 0.6×	29 0.2×	182 2.8×	18	482

Countries citing papers authored by Amina Carlebach

Since Specialization

Citations

This map shows the geographic impact of Amina Carlebach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amina Carlebach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amina Carlebach more than expected).

Fields of papers citing papers by Amina Carlebach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amina Carlebach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amina Carlebach. The network helps show where Amina Carlebach may publish in the future.

Co-authorship network of co-authors of Amina Carlebach

This figure shows the co-authorship network connecting the top 25 collaborators of Amina Carlebach. A scholar is included among the top collaborators of Amina Carlebach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amina Carlebach. Amina Carlebach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Vermehren, Johannes, Amina Carlebach, Thomas A. Lutz, et al.. (2012). Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers. BMC Gastroenterology. 12(1). 27–27. 19 indexed citations

Dietz, Julia, Gaby Knecht, Peter Gute, et al.. (2012). 1104 ANALYSIS OF VIRAL FACTORS, CLINICAL PARAMETERS AND IL28B ASSOCIATED WITH OUTCOME OF PATIENTS WITH ACUTE HEPATITIS C AND HIV COINFECTION. Journal of Hepatology. 56. S434–S435.

Hentig, Nils von, Gaby Knecht, Amina Carlebach, et al.. (2008). The steady-state pharmacokinetics of atazanavir/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors. Journal of Antimicrobial Chemotherapy. 62(3). 579–582. 26 indexed citations

Rockstroh, Jürgen K., M. Vogel, Gerd Klausen, et al.. (2007). [636] THE INFLUENCE OF NUCLEOSIDE FREE HAART ON THE TREATMENT OF CHRONIC HEPATITIS C WITH PEGYLATED INTERFERON/RIBAVIRIN COMBINATION TREATMENT. Journal of Hepatology. 46. S240–S240. 1 indexed citations

Stephan, Christoph, Amina Carlebach, Annette Haberl, et al.. (2007). Dose reduction effective in alleviating symptoms of saquinavir toxicity. International Journal of STD & AIDS. 18(2). 81–84. 3 indexed citations

Schmutz, Guenther, Mark Nelson, Thomas A. Lutz, et al.. (2006). Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection. AIDS. 20(15). 1951–1954. 66 indexed citations

Hentig, Nils von, Amina Carlebach, Peter Gute, et al.. (2006). A comparison of the steady‐state pharmacokinetics of nevirapine in men, nonpregnant women and women in late pregnancy. British Journal of Clinical Pharmacology. 62(5). 552–559. 34 indexed citations

Staszewski, Schlomo, Christoph Stephan, Annette Haberl, et al.. (2006). The LOPSAQ study: 48 week analysis of a boosted double protease inhibitor regimen containing lopinavir/ritonavir plus saquinavir without additional antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 58(5). 1024–1030. 29 indexed citations

Bickel, Markus, Volker Rickerts, Christoph Stephan, et al.. (2005). The Protease Inhibitor Transfer Study (PROTRA 1): abacavir and efavirenz in combination as a substitute for a protease inhibitor in heavily pretreated HIV‐1‐infected patients with undetectable plasma viral load. HIV Medicine. 6(3). 179–184. 1 indexed citations

10.

Stephan, Christoph, Annemarie Berger, Amina Carlebach, et al.. (2005). Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus. Journal of Antimicrobial Chemotherapy. 56(6). 1087–1093. 30 indexed citations

11.

Bickel, Markus, et al.. (2004). Severe CNS side-effect and persistent high efavirenz plasma levels in a patient with HIV/HCV coinfection and liver cirrhosis. Scandinavian Journal of Infectious Diseases. 37(6-7). 520–522. 30 indexed citations

12.

Staszewski, Schlomo, et al.. (2000). A simple, once‐daily dosing regimen for treating HIV‐1 infection in intravenous drug users. HIV Medicine. 1(3). 162–163. 11 indexed citations

13.

Miller, Veronica, et al.. (1999). Virological response to protease inhibitor therapy in an HIV clinic cohort. AIDS. 13(3). 367–373. 102 indexed citations

14.

Miller, Veronica, Schlomo Staszewski, Caroline Sabin, et al.. (1999). CD4 Lymphocyte Count as a Predictor of the Duration of Highly Active Antiretroviral Therapy–Induced Suppression of Human ImmunodeficiencyVirus Load. The Journal of Infectious Diseases. 180(2). 530–533. 60 indexed citations

15.

Staszewski, Schlomo, et al.. (1998). Nevirapine/didanosine/lamivudine once daily in HIV-1-infected intravenous drug users.. PubMed. 3 Suppl 4. 55–6. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact